| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transporter activity | GABRB1 GABRB3 GJB1 GJB2 SLC16A13 PIEZO2 ABCA5 NOX5 KCNH1 TSPO2 SLC35E2A PIEZO1 GJB6 ABCC5 GRIA3 GRIA4 GRID2 ATP11A GRIK3 GRIN2A GRIN2D SLC35E2B ABCA10 KCNH5 | 1.47e-12 | 1289 | 67 | 24 | GO:0005215 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | GABRB1 GABRB3 GJB1 GJB2 SLC16A13 PIEZO2 ABCA5 NOX5 KCNH1 TSPO2 SLC35E2A PIEZO1 GJB6 ABCC5 GRIA3 GRIA4 GRID2 GRIK3 GRIN2A GRIN2D SLC35E2B ABCA10 KCNH5 | 1.95e-12 | 1180 | 67 | 23 | GO:0022857 |
| GeneOntologyMolecularFunction | channel activity | GABRB1 GABRB3 GJB1 GJB2 PIEZO2 NOX5 KCNH1 PIEZO1 GJB6 GRIA3 GRIA4 GRID2 GRIK3 GRIN2A GRIN2D KCNH5 | 1.36e-11 | 525 | 67 | 16 | GO:0015267 |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | GABRB1 GABRB3 GJB1 GJB2 PIEZO2 NOX5 KCNH1 PIEZO1 GJB6 GRIA3 GRIA4 GRID2 GRIK3 GRIN2A GRIN2D KCNH5 | 1.40e-11 | 526 | 67 | 16 | GO:0022803 |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential | 1.51e-11 | 57 | 67 | 8 | GO:1904315 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential | 2.33e-11 | 60 | 67 | 8 | GO:0099529 | |
| GeneOntologyMolecularFunction | transmitter-gated channel activity | 4.53e-11 | 65 | 67 | 8 | GO:0022835 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity | 4.53e-11 | 65 | 67 | 8 | GO:0022824 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential | 1.46e-10 | 24 | 67 | 6 | GO:0099507 | |
| GeneOntologyMolecularFunction | postsynaptic neurotransmitter receptor activity | 1.47e-10 | 75 | 67 | 8 | GO:0098960 | |
| GeneOntologyMolecularFunction | extracellular ligand-gated monoatomic ion channel activity | 1.83e-10 | 77 | 67 | 8 | GO:0005230 | |
| GeneOntologyMolecularFunction | glutamate receptor activity | 3.18e-10 | 27 | 67 | 6 | GO:0008066 | |
| GeneOntologyMolecularFunction | gated channel activity | GABRB1 GABRB3 PIEZO2 KCNH1 PIEZO1 GRIA3 GRIA4 GRID2 GRIK3 GRIN2A GRIN2D KCNH5 | 1.04e-09 | 334 | 67 | 12 | GO:0022836 |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity | 1.52e-09 | 100 | 67 | 8 | GO:0030594 | |
| GeneOntologyMolecularFunction | glutamate-gated receptor activity | 2.19e-09 | 17 | 67 | 5 | GO:0004970 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | GABRB1 GABRB3 PIEZO2 NOX5 KCNH1 PIEZO1 GRIA3 GRIA4 GRID2 GRIK3 GRIN2A GRIN2D KCNH5 | 3.47e-09 | 459 | 67 | 13 | GO:0005216 |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 2.64e-07 | 193 | 67 | 8 | GO:0015276 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 3.09e-07 | 197 | 67 | 8 | GO:0022834 | |
| GeneOntologyMolecularFunction | amino acid transmembrane transporter activity | 1.41e-06 | 105 | 67 | 6 | GO:0015171 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | GABRB1 GABRB3 PIEZO2 NOX5 KCNH1 PIEZO1 GRIA3 GRIA4 GRID2 GRIK3 GRIN2A GRIN2D KCNH5 | 1.93e-06 | 793 | 67 | 13 | GO:0015075 |
| GeneOntologyMolecularFunction | glutamate-gated calcium ion channel activity | 2.00e-06 | 8 | 67 | 3 | GO:0022849 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 2.09e-06 | 343 | 67 | 9 | GO:0005261 | |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | 5.97e-06 | 207 | 67 | 7 | GO:0046943 | |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | 6.02e-06 | 293 | 67 | 8 | GO:0008514 | |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | 6.16e-06 | 208 | 67 | 7 | GO:0005342 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | GABRB1 GABRB3 IL12RB1 NPBWR1 TAS2R5 TLR1 GRIA3 GRIA4 GRID2 GRIK3 GRIN2A GRIN2D TAS2R20 TAS2R46 IL1RAP F2RL2 | 7.50e-06 | 1353 | 67 | 16 | GO:0004888 |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | GABRB1 GABRB3 NOX5 KCNH1 ABCC5 GRIA3 GRIA4 GRIK3 GRIN2A GRIN2D KCNH5 | 4.05e-05 | 758 | 67 | 11 | GO:0015318 |
| GeneOntologyMolecularFunction | AMPA glutamate receptor activity | 6.63e-05 | 4 | 67 | 2 | GO:0004971 | |
| GeneOntologyMolecularFunction | gap junction channel activity | 7.88e-05 | 25 | 67 | 3 | GO:0005243 | |
| GeneOntologyMolecularFunction | peptide binding | 9.33e-05 | 318 | 67 | 7 | GO:0042277 | |
| GeneOntologyMolecularFunction | bitter taste receptor activity | 9.97e-05 | 27 | 67 | 3 | GO:0033038 | |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 1.52e-04 | 31 | 67 | 3 | GO:0099604 | |
| GeneOntologyMolecularFunction | taste receptor activity | 1.83e-04 | 33 | 67 | 3 | GO:0008527 | |
| GeneOntologyMolecularFunction | wide pore channel activity | 2.59e-04 | 37 | 67 | 3 | GO:0022829 | |
| GeneOntologyMolecularFunction | NMDA glutamate receptor activity | 3.07e-04 | 8 | 67 | 2 | GO:0004972 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | 3.60e-04 | 664 | 67 | 9 | GO:0008324 | |
| GeneOntologyMolecularFunction | gap junction channel activity involved in cell communication by electrical coupling | 3.93e-04 | 9 | 67 | 2 | GO:1903763 | |
| GeneOntologyMolecularFunction | ABC-type transporter activity | 5.96e-04 | 49 | 67 | 3 | GO:0140359 | |
| GeneOntologyMolecularFunction | AP-2 adaptor complex binding | 9.83e-04 | 14 | 67 | 2 | GO:0035612 | |
| GeneOntologyMolecularFunction | glutamate binding | 9.83e-04 | 14 | 67 | 2 | GO:0016595 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | 1.15e-03 | 627 | 67 | 8 | GO:0022890 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic cation channel activity | 1.26e-03 | 140 | 67 | 4 | GO:0099094 | |
| GeneOntologyMolecularFunction | NAD+ nucleotidase, cyclic ADP-ribose generating | 1.29e-03 | 16 | 67 | 2 | GO:0061809 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on glycosyl bonds | 1.40e-03 | 144 | 67 | 4 | GO:0016798 | |
| GeneOntologyMolecularFunction | GABA-gated chloride ion channel activity | 1.64e-03 | 18 | 67 | 2 | GO:0022851 | |
| GeneOntologyMolecularFunction | mechanosensitive monoatomic ion channel activity | 1.64e-03 | 18 | 67 | 2 | GO:0008381 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic cation channel activity | 1.71e-03 | 152 | 67 | 4 | GO:0022843 | |
| GeneOntologyMolecularFunction | GABA-A receptor activity | 1.83e-03 | 19 | 67 | 2 | GO:0004890 | |
| GeneOntologyMolecularFunction | GABA receptor activity | 2.45e-03 | 22 | 67 | 2 | GO:0016917 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | 3.27e-03 | 182 | 67 | 4 | GO:0005244 | |
| GeneOntologyMolecularFunction | voltage-gated channel activity | 3.40e-03 | 184 | 67 | 4 | GO:0022832 | |
| GeneOntologyMolecularFunction | nuclear localization sequence binding | 3.69e-03 | 27 | 67 | 2 | GO:0008139 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 4.65e-03 | 465 | 67 | 6 | GO:0046873 | |
| GeneOntologyMolecularFunction | amyloid-beta binding | 4.89e-03 | 102 | 67 | 3 | GO:0001540 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | 5.25e-03 | 477 | 67 | 6 | GO:0022804 | |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 5.88e-03 | 109 | 67 | 3 | GO:0042626 | |
| GeneOntologyMolecularFunction | hydrolase activity, hydrolyzing N-glycosyl compounds | 8.36e-03 | 41 | 67 | 2 | GO:0016799 | |
| GeneOntologyMolecularFunction | potassium channel activity | 9.14e-03 | 128 | 67 | 3 | GO:0005267 | |
| GeneOntologyMolecularFunction | calcium channel activity | 9.34e-03 | 129 | 67 | 3 | GO:0005262 | |
| GeneOntologyBiologicalProcess | ligand-gated ion channel signaling pathway | 3.60e-09 | 40 | 68 | 6 | GO:1990806 | |
| GeneOntologyBiologicalProcess | ionotropic glutamate receptor signaling pathway | 2.56e-08 | 27 | 68 | 5 | GO:0035235 | |
| GeneOntologyBiologicalProcess | regulation of membrane potential | GABRB1 GABRB3 PIEZO2 KCNH1 PIEZO1 PKP2 GRIA3 GRIA4 GRID2 GRIK3 GRIN2A GRIN2D KCNH5 | 2.97e-08 | 559 | 68 | 13 | GO:0042391 |
| GeneOntologyBiologicalProcess | glutamate receptor signaling pathway | 4.03e-08 | 59 | 68 | 6 | GO:0007215 | |
| GeneOntologyBiologicalProcess | regulation of presynaptic membrane potential | 6.30e-08 | 32 | 68 | 5 | GO:0099505 | |
| GeneOntologyBiologicalProcess | regulation of postsynaptic membrane potential | 1.36e-07 | 180 | 68 | 8 | GO:0060078 | |
| GeneOntologyBiologicalProcess | startle response | 2.29e-07 | 41 | 68 | 5 | GO:0001964 | |
| GeneOntologyBiologicalProcess | gap junction assembly | 4.03e-07 | 19 | 68 | 4 | GO:0016264 | |
| GeneOntologyBiologicalProcess | synaptic transmission, glutamatergic | 4.85e-06 | 132 | 68 | 6 | GO:0035249 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | GABRB1 GABRB3 PIEZO2 NOX5 KCNH1 PIEZO1 PKP2 ABCC5 GRIA3 GRIA4 GRID2 SPG11 GRIK3 GRIN2A GRIN2D KCNH5 | 7.43e-06 | 1374 | 68 | 16 | GO:0006811 |
| GeneOntologyBiologicalProcess | trans-synaptic signaling | GABRB1 GABRB3 NPBWR1 OTOF KCNH1 GRIA3 GRIA4 GRID2 SPG11 GRIK3 GRIN2A GRIN2D IL1RAP | 1.02e-05 | 939 | 68 | 13 | GO:0099537 |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | GABRB1 GABRB3 PIEZO2 NOX5 KCNH1 PIEZO1 ABCC5 GRIA3 GRIA4 GRID2 GRIK3 GRIN2A GRIN2D KCNH5 | 1.33e-05 | 1115 | 68 | 14 | GO:0034220 |
| GeneOntologyBiologicalProcess | synaptic signaling | GABRB1 GABRB3 NPBWR1 OTOF KCNH1 GRIA3 GRIA4 GRID2 SPG11 GRIK3 GRIN2A GRIN2D IL1RAP | 1.53e-05 | 976 | 68 | 13 | GO:0099536 |
| GeneOntologyBiologicalProcess | anterograde trans-synaptic signaling | GABRB1 GABRB3 NPBWR1 OTOF KCNH1 GRIA3 GRIA4 GRID2 SPG11 GRIK3 GRIN2A GRIN2D | 4.70e-05 | 931 | 68 | 12 | GO:0098916 |
| GeneOntologyBiologicalProcess | chemical synaptic transmission | GABRB1 GABRB3 NPBWR1 OTOF KCNH1 GRIA3 GRIA4 GRID2 SPG11 GRIK3 GRIN2A GRIN2D | 4.70e-05 | 931 | 68 | 12 | GO:0007268 |
| GeneOntologyBiologicalProcess | epididymis development | 1.06e-04 | 5 | 68 | 2 | GO:1905867 | |
| GeneOntologyBiologicalProcess | detection of mechanical stimulus | 1.10e-04 | 75 | 68 | 4 | GO:0050982 | |
| GeneOntologyBiologicalProcess | chemical synaptic transmission, postsynaptic | 1.25e-04 | 147 | 68 | 5 | GO:0099565 | |
| GeneOntologyBiologicalProcess | sensory perception of mechanical stimulus | 1.33e-04 | 238 | 68 | 6 | GO:0050954 | |
| GeneOntologyBiologicalProcess | cell communication by electrical coupling | 2.08e-04 | 35 | 68 | 3 | GO:0010644 | |
| GeneOntologyBiologicalProcess | cellular response to histamine | 2.23e-04 | 7 | 68 | 2 | GO:0071420 | |
| GeneOntologyBiologicalProcess | gap junction-mediated intercellular transport | 2.23e-04 | 7 | 68 | 2 | GO:1990349 | |
| GeneOntologyBiologicalProcess | regulation of synaptic transmission, glutamatergic | 2.43e-04 | 92 | 68 | 4 | GO:0051966 | |
| GeneOntologyBiologicalProcess | modulation of chemical synaptic transmission | 3.14e-04 | 663 | 68 | 9 | GO:0050804 | |
| GeneOntologyBiologicalProcess | regulation of trans-synaptic signaling | 3.18e-04 | 664 | 68 | 9 | GO:0099177 | |
| GeneOntologyBiologicalProcess | cell junction organization | GABRB3 GJB1 GJB2 PCDHGC4 GJB6 PKP2 GRID2 NBEA SPG11 GRIN2A IL1RAP | 3.19e-04 | 974 | 68 | 11 | GO:0034330 |
| GeneOntologyBiologicalProcess | positive regulation of synaptic transmission, glutamatergic | 3.85e-04 | 43 | 68 | 3 | GO:0051968 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception of bitter taste | 4.12e-04 | 44 | 68 | 3 | GO:0001580 | |
| GeneOntologyBiologicalProcess | sensory perception of bitter taste | 5.33e-04 | 48 | 68 | 3 | GO:0050913 | |
| GeneOntologyBiologicalProcess | intercellular transport | 5.78e-04 | 11 | 68 | 2 | GO:0010496 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception of taste | 6.01e-04 | 50 | 68 | 3 | GO:0050912 | |
| GeneOntologyBiologicalProcess | response to histamine | 6.92e-04 | 12 | 68 | 2 | GO:0034776 | |
| GeneOntologyBiologicalProcess | neuromuscular process | 8.81e-04 | 225 | 68 | 5 | GO:0050905 | |
| GeneOntologyBiologicalProcess | detection of mechanical stimulus involved in sensory perception | 8.83e-04 | 57 | 68 | 3 | GO:0050974 | |
| GeneOntologyBiologicalProcess | excitatory chemical synaptic transmission | 1.25e-03 | 16 | 68 | 2 | GO:0098976 | |
| GeneOntologyCellularComponent | plasma membrane protein complex | IL12RB1 GJB1 GJB2 NOX5 KCNH1 GJB6 TLR1 TRGV3 TRGV5 GRIA3 GRIA4 GRID2 GRIK3 GRIN2A GRIN2D KCNH5 | 3.18e-09 | 785 | 68 | 16 | GO:0098797 |
| GeneOntologyCellularComponent | ionotropic glutamate receptor complex | 6.97e-09 | 45 | 68 | 6 | GO:0008328 | |
| GeneOntologyCellularComponent | neurotransmitter receptor complex | 1.34e-08 | 50 | 68 | 6 | GO:0098878 | |
| GeneOntologyCellularComponent | postsynaptic specialization membrane | 1.77e-08 | 201 | 68 | 9 | GO:0099634 | |
| GeneOntologyCellularComponent | membrane protein complex | GABRB1 GABRB3 IL12RB1 GJB1 GJB2 SYNE3 NOX5 KCNH1 GJB6 TLR1 TRGV3 TRGV5 GRIA3 GRIA4 GRID2 GRIK3 GRIN2A GRIN2D KCNH5 | 1.79e-07 | 1498 | 68 | 19 | GO:0098796 |
| GeneOntologyCellularComponent | plasma membrane signaling receptor complex | IL12RB1 TLR1 TRGV3 TRGV5 GRIA3 GRIA4 GRID2 GRIK3 GRIN2A GRIN2D | 1.87e-07 | 350 | 68 | 10 | GO:0098802 |
| GeneOntologyCellularComponent | receptor complex | GABRB1 GABRB3 IL12RB1 TLR1 TRGV3 TRGV5 GRIA3 GRIA4 GRID2 GRIK3 GRIN2A GRIN2D | 3.34e-07 | 581 | 68 | 12 | GO:0043235 |
| GeneOntologyCellularComponent | monoatomic ion channel complex | GABRB1 GABRB3 KCNH1 GRIA3 GRIA4 GRID2 GRIK3 GRIN2A GRIN2D KCNH5 | 3.80e-07 | 378 | 68 | 10 | GO:0034702 |
| GeneOntologyCellularComponent | postsynaptic membrane | GABRB1 GABRB3 KCNH1 GRIA3 GRIA4 GRID2 NBEA GRIK3 GRIN2A GRIN2D | 7.12e-07 | 405 | 68 | 10 | GO:0045211 |
| GeneOntologyCellularComponent | postsynaptic density membrane | 7.78e-07 | 157 | 68 | 7 | GO:0098839 | |
| GeneOntologyCellularComponent | transporter complex | GABRB1 GABRB3 KCNH1 GRIA3 GRIA4 GRID2 ATP11A GRIK3 GRIN2A GRIN2D KCNH5 | 1.49e-06 | 550 | 68 | 11 | GO:1990351 |
| GeneOntologyCellularComponent | synaptic membrane | GABRB1 GABRB3 OTOF KCNH1 GRIA3 GRIA4 GRID2 NBEA GRIK3 GRIN2A GRIN2D | 2.62e-06 | 583 | 68 | 11 | GO:0097060 |
| GeneOntologyCellularComponent | presynaptic membrane | 3.19e-06 | 277 | 68 | 8 | GO:0042734 | |
| GeneOntologyCellularComponent | presynaptic active zone membrane | 5.51e-06 | 78 | 68 | 5 | GO:0048787 | |
| GeneOntologyCellularComponent | transmembrane transporter complex | GABRB1 GABRB3 KCNH1 GRIA3 GRIA4 GRID2 GRIK3 GRIN2A GRIN2D KCNH5 | 6.98e-06 | 523 | 68 | 10 | GO:1902495 |
| GeneOntologyCellularComponent | parallel fiber to Purkinje cell synapse | 1.15e-05 | 43 | 68 | 4 | GO:0098688 | |
| GeneOntologyCellularComponent | terminal bouton | 1.52e-05 | 96 | 68 | 5 | GO:0043195 | |
| GeneOntologyCellularComponent | postsynaptic specialization | 3.52e-05 | 503 | 68 | 9 | GO:0099572 | |
| GeneOntologyCellularComponent | connexin complex | 4.85e-05 | 22 | 68 | 3 | GO:0005922 | |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | GJB1 SYNE3 MOGS OTOF NOX5 TSPO2 PIEZO1 TMCC2 ELAPOR1 ATP11A BFAR GRIN2A GRIN2D G6PC2 | 7.81e-05 | 1327 | 68 | 14 | GO:0042175 |
| GeneOntologyCellularComponent | presynaptic active zone | 9.63e-05 | 141 | 68 | 5 | GO:0048786 | |
| GeneOntologyCellularComponent | kainate selective glutamate receptor complex | 1.55e-04 | 6 | 68 | 2 | GO:0032983 | |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | GJB1 MOGS OTOF NOX5 TSPO2 PIEZO1 TMCC2 ELAPOR1 ATP11A BFAR GRIN2A GRIN2D G6PC2 | 2.36e-04 | 1293 | 68 | 13 | GO:0005789 |
| GeneOntologyCellularComponent | gap junction | 2.36e-04 | 37 | 68 | 3 | GO:0005921 | |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | GJB1 MOGS OTOF NOX5 TSPO2 PIEZO1 TMCC2 ELAPOR1 ATP11A BFAR GRIN2A GRIN2D G6PC2 | 2.47e-04 | 1299 | 68 | 13 | GO:0098827 |
| GeneOntologyCellularComponent | potassium channel complex | 3.69e-04 | 104 | 68 | 4 | GO:0034705 | |
| GeneOntologyCellularComponent | NMDA selective glutamate receptor complex | 3.70e-04 | 9 | 68 | 2 | GO:0017146 | |
| GeneOntologyCellularComponent | excitatory synapse | 4.11e-04 | 107 | 68 | 4 | GO:0060076 | |
| GeneOntologyCellularComponent | axon terminus | 6.08e-04 | 210 | 68 | 5 | GO:0043679 | |
| GeneOntologyCellularComponent | postsynaptic density | 6.48e-04 | 451 | 68 | 7 | GO:0014069 | |
| GeneOntologyCellularComponent | asymmetric synapse | 9.00e-04 | 477 | 68 | 7 | GO:0032279 | |
| GeneOntologyCellularComponent | neuron projection terminus | 9.71e-04 | 233 | 68 | 5 | GO:0044306 | |
| GeneOntologyCellularComponent | neuron to neuron synapse | 1.53e-03 | 523 | 68 | 7 | GO:0098984 | |
| GeneOntologyCellularComponent | postsynapse | GABRB1 GABRB3 KCNH1 GRIA3 GRIA4 GRID2 NBEA GRIK3 GRIN2A GRIN2D | 1.60e-03 | 1018 | 68 | 10 | GO:0098794 |
| GeneOntologyCellularComponent | GABA-A receptor complex | 1.72e-03 | 19 | 68 | 2 | GO:1902711 | |
| GeneOntologyCellularComponent | GABA receptor complex | 2.10e-03 | 21 | 68 | 2 | GO:1902710 | |
| GeneOntologyCellularComponent | presynapse | 2.22e-03 | 886 | 68 | 9 | GO:0098793 | |
| GeneOntologyCellularComponent | cytoplasmic vesicle membrane | GABRB3 OTOF ABCA5 KCNH1 TLR1 ELAPOR1 ABCC5 GRIA3 GRIA4 ATP11A GRIN2A | 3.12e-03 | 1307 | 68 | 11 | GO:0030659 |
| GeneOntologyCellularComponent | vesicle membrane | GABRB3 OTOF ABCA5 KCNH1 TLR1 ELAPOR1 ABCC5 GRIA3 GRIA4 ATP11A GRIN2A | 3.47e-03 | 1325 | 68 | 11 | GO:0012506 |
| GeneOntologyCellularComponent | sodium channel complex | 4.00e-03 | 29 | 68 | 2 | GO:0034706 | |
| GeneOntologyCellularComponent | AMPA glutamate receptor complex | 4.28e-03 | 30 | 68 | 2 | GO:0032281 | |
| GeneOntologyCellularComponent | glutamatergic synapse | 4.90e-03 | 817 | 68 | 8 | GO:0098978 | |
| GeneOntologyCellularComponent | dendrite | 6.54e-03 | 858 | 68 | 8 | GO:0030425 | |
| GeneOntologyCellularComponent | dendritic tree | 6.63e-03 | 860 | 68 | 8 | GO:0097447 | |
| GeneOntologyCellularComponent | cation channel complex | 7.23e-03 | 235 | 68 | 4 | GO:0034703 | |
| GeneOntologyCellularComponent | dendritic spine | 8.00e-03 | 242 | 68 | 4 | GO:0043197 | |
| GeneOntologyCellularComponent | neuron spine | 8.58e-03 | 247 | 68 | 4 | GO:0044309 | |
| HumanPheno | Abnormal nervous system electrophysiology | GABRB1 GABRB3 GJB1 GJB2 PIEZO2 WWOX MOGS OTOF ABCA5 SZT2 KCNH1 GJB6 GRIA3 GRIA4 NBEA SPG11 ATP11A GRIN2A GRIN2D | 2.20e-07 | 924 | 32 | 19 | HP:0001311 |
| HumanPheno | Abnormality of central nervous system electrophysiology | GABRB1 GABRB3 GJB2 PIEZO2 WWOX MOGS OTOF ABCA5 SZT2 KCNH1 GJB6 GRIA3 GRIA4 NBEA SPG11 GRIN2A GRIN2D | 3.05e-07 | 738 | 32 | 17 | HP:0030178 |
| HumanPheno | Epileptic encephalopathy | 6.60e-06 | 119 | 32 | 7 | HP:0200134 | |
| HumanPheno | Short attention span | GABRB3 PIEZO2 WWOX SZT2 TNPO2 TMEM270 GRIA4 NBEA SPG11 GRIN2A GRIN2D KCNH5 | 3.54e-05 | 517 | 32 | 12 | HP:0000736 |
| HumanPheno | Reduced attention regulation | GABRB3 PIEZO2 WWOX SZT2 TNPO2 TMEM270 GRIA4 NBEA SPG11 GRIN2A GRIN2D KCNH5 | 4.21e-05 | 526 | 32 | 12 | HP:5200044 |
| HumanPheno | EEG abnormality | GABRB1 GABRB3 WWOX MOGS ABCA5 SZT2 KCNH1 GRIA3 GRIA4 NBEA GRIN2A GRIN2D | 6.34e-05 | 548 | 32 | 12 | HP:0002353 |
| HumanPheno | Atrophy/Degeneration affecting the central nervous system | GJB1 GJB2 PIEZO2 KIDINS220 WWOX MOGS PCDHGC4 SZT2 TNPO2 GJB6 TMEM270 GRIA3 GRIA4 GRID2 SPG11 ATP11A GRIN2A GRIN2D KCNH5 | 8.29e-05 | 1347 | 32 | 19 | HP:0007367 |
| HumanPheno | Interictal epileptiform activity | 1.03e-04 | 319 | 32 | 9 | HP:0011182 | |
| HumanPheno | Lip fissure | 1.14e-04 | 3 | 32 | 2 | HP:0031250 | |
| HumanPheno | Interictal EEG abnormality | 1.19e-04 | 325 | 32 | 9 | HP:0025373 | |
| HumanPheno | Attention deficit hyperactivity disorder | GABRB3 PIEZO2 WWOX SZT2 TNPO2 TMEM270 NBEA GRIN2A GRIN2D KCNH5 | 1.39e-04 | 413 | 32 | 10 | HP:0007018 |
| HumanPheno | Recurrent candida infections | 1.44e-04 | 17 | 32 | 3 | HP:0005401 | |
| HumanPheno | Brain atrophy | KIDINS220 WWOX MOGS PCDHGC4 SZT2 TMEM270 GRIA3 GRIA4 GRID2 SPG11 ATP11A GRIN2A GRIN2D KCNH5 | 1.50e-04 | 802 | 32 | 14 | HP:0012444 |
| HumanPheno | Brain very small | KIDINS220 WWOX MOGS PCDHGC4 SZT2 TMEM270 GRIA3 GRIA4 GRID2 SPG11 ATP11A GRIN2A GRIN2D KCNH5 | 1.50e-04 | 802 | 32 | 14 | HP:0001322 |
| HumanPheno | EEG with abnormally slow frequencies | 1.91e-04 | 88 | 32 | 5 | HP:0011203 | |
| HumanPheno | Tonic seizure | 1.95e-04 | 140 | 32 | 6 | HP:0032792 | |
| HumanPheno | Cerebral atrophy | KIDINS220 WWOX MOGS PCDHGC4 SZT2 TMEM270 GRIA3 GRIA4 SPG11 ATP11A GRIN2A GRIN2D KCNH5 | 2.03e-04 | 718 | 32 | 13 | HP:0002059 |
| HumanPheno | Cobblestone-like hyperkeratosis | 2.28e-04 | 4 | 32 | 2 | HP:0031288 | |
| HumanPheno | Status epilepticus | 2.34e-04 | 207 | 32 | 7 | HP:0002133 | |
| HumanPheno | Developmental regression | GABRB1 GABRB3 WWOX SZT2 TMEM270 NBEA ATP11A GRIN2A GRIN2D KCNH5 | 2.36e-04 | 440 | 32 | 10 | HP:0002376 |
| HumanPheno | Atrophy/Degeneration affecting the cerebrum | KIDINS220 WWOX MOGS PCDHGC4 SZT2 TMEM270 GRIA3 GRIA4 SPG11 ATP11A GRIN2A GRIN2D KCNH5 | 2.51e-04 | 733 | 32 | 13 | HP:0007369 |
| HumanPheno | Cerebral hypoplasia | KIDINS220 WWOX MOGS PCDHGC4 SZT2 TMEM270 GRIA3 GRIA4 GRID2 SPG11 ATP11A GRIN2A GRIN2D KCNH5 | 2.63e-04 | 844 | 32 | 14 | HP:0006872 |
| HumanPheno | Bilateral tonic-clonic seizure with focal onset | 2.81e-04 | 52 | 32 | 4 | HP:0007334 | |
| HumanPheno | EEG with multifocal slow activity | 2.81e-04 | 52 | 32 | 4 | HP:0010844 | |
| HumanPheno | Gait disturbance | GABRB3 GJB1 GJB2 PIEZO2 KIDINS220 WWOX SZT2 TNPO2 GJB6 GBE1 TMEM270 GRIA3 GRIA4 GRID2 NBEA SPG11 GRIN2A GRIN2D | 3.59e-04 | 1356 | 32 | 18 | HP:0001288 |
| HumanPheno | Focal tonic seizure | 3.66e-04 | 23 | 32 | 3 | HP:0011167 | |
| HumanPheno | Dilatated internal auditory canal | 3.78e-04 | 5 | 32 | 2 | HP:0004458 | |
| HumanPheno | Hair follicle neoplasm | 3.78e-04 | 5 | 32 | 2 | HP:0012843 | |
| HumanPheno | Trichilemmoma | 3.78e-04 | 5 | 32 | 2 | HP:0012844 | |
| HumanPheno | Punctate keratitis | 5.65e-04 | 6 | 32 | 2 | HP:0011859 | |
| HumanPheno | Generalized non-motor (absence) seizure | 6.69e-04 | 176 | 32 | 6 | HP:0002121 | |
| MousePheno | abnormal miniature inhibitory postsynaptic current amplitude | 8.77e-05 | 24 | 51 | 3 | MP:0014380 | |
| MousePheno | decreased vertical activity | 9.10e-05 | 203 | 51 | 6 | MP:0002757 | |
| MousePheno | brain atrophy | 9.94e-05 | 25 | 51 | 3 | MP:0012506 | |
| MousePheno | abnormal reflex | GABRB3 PCYOX1L WWOX OTOF GJB6 ABCC5 GRIA3 GRIA4 GRID2 NBEA SPG11 GRIN2A GRIN2D KCNH5 | 1.54e-04 | 1294 | 51 | 14 | MP:0001961 |
| MousePheno | abnormal vertical activity | 1.73e-04 | 439 | 51 | 8 | MP:0020167 | |
| Domain | Iontro_rcpt | 2.77e-11 | 18 | 66 | 6 | IPR001320 | |
| Domain | Lig_chan-Glu_bd | 2.77e-11 | 18 | 66 | 6 | PF10613 | |
| Domain | Iono_rcpt_met | 2.77e-11 | 18 | 66 | 6 | IPR001508 | |
| Domain | Glu/Gly-bd | 2.77e-11 | 18 | 66 | 6 | IPR019594 | |
| Domain | Lig_chan-Glu_bd | 2.77e-11 | 18 | 66 | 6 | SM00918 | |
| Domain | Lig_chan | 2.77e-11 | 18 | 66 | 6 | PF00060 | |
| Domain | PBPe | 2.77e-11 | 18 | 66 | 6 | SM00079 | |
| Domain | ANF_lig-bd_rcpt | 3.29e-09 | 37 | 66 | 6 | IPR001828 | |
| Domain | ANF_receptor | 3.29e-09 | 37 | 66 | 6 | PF01094 | |
| Domain | Peripla_BP_I | 4.59e-09 | 39 | 66 | 6 | IPR028082 | |
| Domain | K_chnl_volt-dep_EAG | 1.23e-05 | 2 | 66 | 2 | IPR003949 | |
| Domain | PIEZO | 1.23e-05 | 2 | 66 | 2 | PF15917 | |
| Domain | Piezo_RRas-bd_dom | 1.23e-05 | 2 | 66 | 2 | IPR031334 | |
| Domain | Piezo | 1.23e-05 | 2 | 66 | 2 | IPR027272 | |
| Domain | Piezo_RRas_bdg | 1.23e-05 | 2 | 66 | 2 | PF12166 | |
| Domain | Piezo_dom | 1.23e-05 | 2 | 66 | 2 | IPR031805 | |
| Domain | GABAAb_rcpt | 3.68e-05 | 3 | 66 | 2 | IPR002289 | |
| Domain | CONNEXINS_1 | 3.92e-05 | 19 | 66 | 3 | PS00407 | |
| Domain | CONNEXINS_2 | 4.60e-05 | 20 | 66 | 3 | PS00408 | |
| Domain | Connexin | 4.60e-05 | 20 | 66 | 3 | IPR000500 | |
| Domain | Connexin_CCC | 4.60e-05 | 20 | 66 | 3 | IPR019570 | |
| Domain | Connexin_N | 4.60e-05 | 20 | 66 | 3 | IPR013092 | |
| Domain | Connexin | 4.60e-05 | 20 | 66 | 3 | PF00029 | |
| Domain | Connexin_CCC | 4.60e-05 | 20 | 66 | 3 | SM01089 | |
| Domain | Connexin_CS | 4.60e-05 | 20 | 66 | 3 | IPR017990 | |
| Domain | CNX | 4.60e-05 | 20 | 66 | 3 | SM00037 | |
| Domain | TAS2R | 1.03e-04 | 26 | 66 | 3 | PF05296 | |
| Domain | T2R | 1.03e-04 | 26 | 66 | 3 | IPR007960 | |
| Domain | ABC_transporter_CS | 4.38e-04 | 42 | 66 | 3 | IPR017871 | |
| Domain | Sugar_P_trans_dom | 5.43e-04 | 10 | 66 | 2 | IPR004853 | |
| Domain | PAS_9 | 5.43e-04 | 10 | 66 | 2 | PF13426 | |
| Domain | TPT | 5.43e-04 | 10 | 66 | 2 | PF03151 | |
| Domain | ABC_tran | 6.51e-04 | 48 | 66 | 3 | PF00005 | |
| Domain | ABC_TRANSPORTER_2 | 6.51e-04 | 48 | 66 | 3 | PS50893 | |
| Domain | ABC_TRANSPORTER_1 | 6.91e-04 | 49 | 66 | 3 | PS00211 | |
| Domain | ABC_transporter-like | 7.34e-04 | 50 | 66 | 3 | IPR003439 | |
| Domain | ABC_A | 7.93e-04 | 12 | 66 | 2 | IPR026082 | |
| Domain | K_chnl_volt-dep_EAG/ELK/ERG | 1.09e-03 | 14 | 66 | 2 | IPR003938 | |
| Domain | TIR | 2.47e-03 | 21 | 66 | 2 | SM00255 | |
| Domain | TIR | 2.71e-03 | 22 | 66 | 2 | PF01582 | |
| Domain | GABAA/Glycine_rcpt | 2.97e-03 | 23 | 66 | 2 | IPR006028 | |
| Domain | - | 2.97e-03 | 23 | 66 | 2 | 3.40.50.10140 | |
| Domain | PAS-assoc_C | 3.23e-03 | 24 | 66 | 2 | IPR000700 | |
| Domain | TIR | 3.23e-03 | 24 | 66 | 2 | PS50104 | |
| Domain | PAS | 3.50e-03 | 25 | 66 | 2 | PF00989 | |
| Domain | PAS_fold | 3.50e-03 | 25 | 66 | 2 | IPR013767 | |
| Domain | TIR_dom | 3.50e-03 | 25 | 66 | 2 | IPR000157 | |
| Domain | PAC | 3.78e-03 | 26 | 66 | 2 | IPR001610 | |
| Domain | PAC | 3.78e-03 | 26 | 66 | 2 | SM00086 | |
| Domain | PAC | 3.78e-03 | 26 | 66 | 2 | PS50113 | |
| Domain | Arm | 5.35e-03 | 31 | 66 | 2 | PF00514 | |
| Domain | CNMP_BINDING_1 | 5.70e-03 | 32 | 66 | 2 | PS00888 | |
| Domain | CNMP_BINDING_2 | 5.70e-03 | 32 | 66 | 2 | PS00889 | |
| Domain | PAS | 5.70e-03 | 32 | 66 | 2 | SM00091 | |
| Domain | cNMP | 6.41e-03 | 34 | 66 | 2 | SM00100 | |
| Domain | PAS | 6.41e-03 | 34 | 66 | 2 | IPR000014 | |
| Domain | PAS | 6.41e-03 | 34 | 66 | 2 | PS50112 | |
| Domain | cNMP_binding | 6.41e-03 | 34 | 66 | 2 | PF00027 | |
| Domain | cNMP-bd_dom | 6.79e-03 | 35 | 66 | 2 | IPR000595 | |
| Domain | CNMP_BINDING_3 | 6.79e-03 | 35 | 66 | 2 | PS50042 | |
| Domain | ARM-type_fold | 6.92e-03 | 339 | 66 | 5 | IPR016024 | |
| Pathway | KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION | GABRB1 GABRB3 NPBWR1 GRIA3 GRIA4 GRID2 GRIK3 GRIN2A GRIN2D F2RL2 | 2.08e-08 | 272 | 48 | 10 | M13380 |
| Pathway | REACTOME_NEURONAL_SYSTEM | GABRB1 GABRB3 KCNH1 GRIA3 GRIA4 NBEA GRIK3 GRIN2A GRIN2D IL1RAP KCNH5 | 9.69e-08 | 411 | 48 | 11 | M735 |
| Pathway | REACTOME_NEURONAL_SYSTEM | GABRB1 GABRB3 KCNH1 GRIA3 GRIA4 GRIK3 GRIN2A GRIN2D IL1RAP KCNH5 | 1.47e-07 | 335 | 48 | 10 | MM14503 |
| Pathway | WP_NRXN1_DELETION_SYNDROME | 3.50e-07 | 18 | 48 | 4 | M48098 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION | 4.00e-07 | 205 | 48 | 8 | M752 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION | 5.20e-07 | 144 | 48 | 7 | MM14501 | |
| Pathway | REACTOME_SYNAPTIC_ADHESION_LIKE_MOLECULES | 5.51e-07 | 20 | 48 | 4 | MM15485 | |
| Pathway | REACTOME_SYNAPTIC_ADHESION_LIKE_MOLECULES | 6.79e-07 | 21 | 48 | 4 | M27736 | |
| Pathway | REACTOME_UNBLOCKING_OF_NMDA_RECEPTORS_GLUTAMATE_BINDING_AND_ACTIVATION | 6.79e-07 | 21 | 48 | 4 | M838 | |
| Pathway | REACTOME_UNBLOCKING_OF_NMDA_RECEPTORS_GLUTAMATE_BINDING_AND_ACTIVATION | 8.27e-07 | 22 | 48 | 4 | MM15104 | |
| Pathway | REACTOME_PROTEIN_PROTEIN_INTERACTIONS_AT_SYNAPSES | 3.05e-06 | 67 | 48 | 5 | MM15327 | |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | 3.17e-06 | 270 | 48 | 8 | M15514 | |
| Pathway | WP_DRAVET_SYNDROME_SCN1AA1783V_POINT_MUTATION_MODEL | 4.67e-06 | 73 | 48 | 5 | MM16641 | |
| Pathway | REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS | 5.73e-06 | 35 | 48 | 4 | MM15109 | |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | 6.66e-06 | 211 | 48 | 7 | MM14502 | |
| Pathway | WP_COMMON_PATHWAYS_UNDERLYING_DRUG_ADDICTION | 1.09e-05 | 41 | 48 | 4 | M39655 | |
| Pathway | REACTOME_PROTEIN_PROTEIN_INTERACTIONS_AT_SYNAPSES | 1.11e-05 | 87 | 48 | 5 | M27617 | |
| Pathway | REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS | 1.62e-05 | 94 | 48 | 5 | M2843 | |
| Pathway | WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING | 1.09e-04 | 140 | 48 | 5 | M42572 | |
| Pathway | REACTOME_ASSEMBLY_AND_CELL_SURFACE_PRESENTATION_OF_NMDA_RECEPTORS | 1.13e-04 | 5 | 48 | 2 | MM15655 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TRANSPORT_OF_CALCIUM | 1.13e-04 | 5 | 48 | 2 | M47667 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_PDYN_TO_TRANSPORT_OF_CALCIUM | 1.69e-04 | 6 | 48 | 2 | M47668 | |
| Pathway | REACTOME_GAP_JUNCTION_ASSEMBLY | 1.71e-04 | 32 | 48 | 3 | MM14730 | |
| Pathway | WP_ADHD_AND_AUTISM_ASD_PATHWAYS | 2.25e-04 | 367 | 48 | 7 | M48346 | |
| Pathway | REACTOME_GAP_JUNCTION_ASSEMBLY | 2.87e-04 | 38 | 48 | 3 | M14981 | |
| Pathway | REACTOME_METABOLISM_OF_CARBOHYDRATES | 2.98e-04 | 271 | 48 | 6 | MM15406 | |
| Pathway | REACTOME_CLASS_C_3_METABOTROPIC_GLUTAMATE_PHEROMONE_RECEPTORS | 3.11e-04 | 39 | 48 | 3 | M793 | |
| Pathway | REACTOME_METABOLISM_OF_CARBOHYDRATES | 4.12e-04 | 288 | 48 | 6 | M16864 | |
| Pathway | KEGG_ABC_TRANSPORTERS | 4.45e-04 | 44 | 48 | 3 | M11911 | |
| Pathway | REACTOME_GAP_JUNCTION_TRAFFICKING_AND_REGULATION | 4.45e-04 | 44 | 48 | 3 | MM14606 | |
| Pathway | REACTOME_ASSEMBLY_AND_CELL_SURFACE_PRESENTATION_OF_NMDA_RECEPTORS | 4.45e-04 | 44 | 48 | 3 | M27934 | |
| Pathway | REACTOME_SENSORY_PERCEPTION_OF_TASTE | 5.41e-04 | 47 | 48 | 3 | M42524 | |
| Pathway | REACTOME_GAP_JUNCTION_TRAFFICKING_AND_REGULATION | 6.88e-04 | 51 | 48 | 3 | M26972 | |
| Pathway | KEGG_TASTE_TRANSDUCTION | 7.28e-04 | 52 | 48 | 3 | M5785 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_ENTRY_LIGAND_GATED_CA2_CHANNEL | 7.33e-04 | 12 | 48 | 2 | M47953 | |
| Pathway | REACTOME_SIGNALING_BY_ERBB4 | 1.00e-03 | 58 | 48 | 3 | M544 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_TRANSPORT_OF_CALCIUM | 1.16e-03 | 15 | 48 | 2 | M47691 | |
| Pathway | REACTOME_TRAFFICKING_OF_GLUR2_CONTAINING_AMPA_RECEPTORS | 1.32e-03 | 16 | 48 | 2 | MM15048 | |
| Pathway | REACTOME_TRAFFICKING_OF_GLUR2_CONTAINING_AMPA_RECEPTORS | 1.49e-03 | 17 | 48 | 2 | M5488 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_TRANSPORT_OF_CALCIUM | 1.68e-03 | 18 | 48 | 2 | M47761 | |
| Pathway | REACTOME_ABC_TRANSPORTERS_IN_LIPID_HOMEOSTASIS | 1.68e-03 | 18 | 48 | 2 | M524 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_TRANSPORT_OF_CALCIUM | 1.87e-03 | 19 | 48 | 2 | M47677 | |
| Pathway | BIOCARTA_NOS1_PATHWAY | 2.07e-03 | 20 | 48 | 2 | MM1445 | |
| Pathway | BIOCARTA_NOS1_PATHWAY | 2.29e-03 | 21 | 48 | 2 | M11650 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_NMDA_RECEPTOR_MEDIATED_NEURONAL_TRANSMISSION | 2.29e-03 | 21 | 48 | 2 | M27944 | |
| Pathway | WP_PKCGAMMA_CALCIUM_SIGNALING_IN_ATAXIA | 2.51e-03 | 22 | 48 | 2 | M39795 | |
| Pathway | REACTOME_LONG_TERM_POTENTIATION | 2.74e-03 | 23 | 48 | 2 | M27949 | |
| Pathway | WP_MTHFR_DEFICIENCY | 2.99e-03 | 24 | 48 | 2 | M39755 | |
| Pathway | REACTOME_G_ALPHA_I_SIGNALLING_EVENTS | 4.15e-03 | 314 | 48 | 5 | M600 | |
| Pathway | REACTOME_TRAFFICKING_OF_AMPA_RECEPTORS | 4.35e-03 | 29 | 48 | 2 | MM15028 | |
| Pathway | WP_GABA_RECEPTOR_SIGNALING | 4.96e-03 | 31 | 48 | 2 | M39369 | |
| Pathway | REACTOME_TRAFFICKING_OF_AMPA_RECEPTORS | 4.96e-03 | 31 | 48 | 2 | M7223 | |
| Pathway | REACTOME_SENSORY_PERCEPTION_OF_TASTE | 4.96e-03 | 31 | 48 | 2 | MM15691 | |
| Pathway | REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT | 5.16e-03 | 103 | 48 | 3 | M758 | |
| Pubmed | 2.74e-10 | 81 | 69 | 7 | 22723691 | ||
| Pubmed | 4.94e-10 | 7 | 69 | 4 | 21368048 | ||
| Pubmed | Glutamate can act as a signaling molecule in mouse preimplantation embryos†. | 1.09e-09 | 24 | 69 | 5 | 35746896 | |
| Pubmed | 7.47e-09 | 3 | 69 | 3 | 22098503 | ||
| Pubmed | Glutamatergic gene variants impact the clinical profile of efficacy and side effects of haloperidol. | 1.00e-08 | 13 | 69 | 4 | 20859245 | |
| Pubmed | 1.90e-08 | 15 | 69 | 4 | 9481670 | ||
| Pubmed | 3.05e-08 | 45 | 69 | 5 | 25979088 | ||
| Pubmed | 7.45e-08 | 5 | 69 | 3 | 11488959 | ||
| Pubmed | Glutamate receptors in cortical plasticity: molecular and cellular biology. | 2.60e-07 | 7 | 69 | 3 | 9016303 | |
| Pubmed | Glutamate receptors: brain function and signal transduction. | 2.60e-07 | 7 | 69 | 3 | 9651535 | |
| Pubmed | Transmembrane topology of the glutamate receptor subunit GluR6. | 4.16e-07 | 8 | 69 | 3 | 8163463 | |
| Pubmed | 4.16e-07 | 8 | 69 | 3 | 19125103 | ||
| Pubmed | 6.22e-07 | 9 | 69 | 3 | 20089884 | ||
| Pubmed | 6.22e-07 | 9 | 69 | 3 | 19864490 | ||
| Pubmed | 6.22e-07 | 9 | 69 | 3 | 14595769 | ||
| Pubmed | Expression of glutamate receptor subunit genes during development of the mouse retina. | 6.22e-07 | 9 | 69 | 3 | 9051806 | |
| Pubmed | 8.88e-07 | 10 | 69 | 3 | 19523148 | ||
| Pubmed | Expression of connexins in embryonic mouse neocortical development. | 8.88e-07 | 10 | 69 | 3 | 17640036 | |
| Pubmed | 2.68e-06 | 14 | 69 | 3 | 22768092 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 31162818 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 28012540 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 19723508 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 23503914 | ||
| Pubmed | GABAA receptors involved in sleep and anaesthesia: β1- versus β3-containing assemblies. | 3.88e-06 | 2 | 69 | 2 | 21735059 | |
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 23700267 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 25715449 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 20236118 | ||
| Pubmed | Connexin 26 variants and auditory neuropathy/dys-synchrony among children in schools for the deaf. | 3.88e-06 | 2 | 69 | 2 | 16222667 | |
| Pubmed | [Influence of Cx26/Cx32 gap junction channel on antineoplastic effect of etoposide in Hela cells]. | 3.88e-06 | 2 | 69 | 2 | 22445976 | |
| Pubmed | Kinetic properties of human AMPA-type glutamate receptors expressed in HEK293 cells. | 3.88e-06 | 2 | 69 | 2 | 12670305 | |
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 26490746 | ||
| Pubmed | SLC35E2 promoter mutation as a prognostic marker of esophageal squamous cell carcinoma. | 3.88e-06 | 2 | 69 | 2 | 35247439 | |
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 20022641 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 19887791 | ||
| Pubmed | [Feeling the pressure? Identification of two proteins activated by mechanical forces]. | 3.88e-06 | 2 | 69 | 2 | 21299953 | |
| Pubmed | Control of kinetic properties of AMPA receptor channels by nuclear RNA editing. | 3.88e-06 | 2 | 69 | 2 | 7992055 | |
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 26950270 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 21060893 | ||
| Pubmed | Hearing impairment in Dutch patients with connexin 26 (GJB2) and connexin 30 (GJB6) mutations. | 3.88e-06 | 2 | 69 | 2 | 15656949 | |
| Pubmed | The association between GJB2 mutation and GJB6 gene in non syndromic hearing loss school children. | 3.88e-06 | 2 | 69 | 2 | 22106692 | |
| Pubmed | Multiple modes for conferring surface expression of homomeric beta1 GABAA receptors. | 3.88e-06 | 2 | 69 | 2 | 18650446 | |
| Pubmed | GJB2 and GJB6 Genetic Variant Curation in an Argentinean Non-Syndromic Hearing-Impaired Cohort. | 3.88e-06 | 2 | 69 | 2 | 33096615 | |
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 20442751 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 19844737 | ||
| Pubmed | Spontaneous alternation, motor activity, and spatial learning in hot-foot mutant mice. | 3.88e-06 | 2 | 69 | 2 | 8568721 | |
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 17368814 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 26265468 | ||
| Pubmed | Structural studies of N-terminal mutants of Connexin 26 and Connexin 32 using (1)H NMR spectroscopy. | 3.88e-06 | 2 | 69 | 2 | 27378082 | |
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 25288386 | ||
| Pubmed | Piezo1 expression in chondrocytes controls endochondral ossification and osteoarthritis development. | 3.88e-06 | 2 | 69 | 2 | 38395992 | |
| Pubmed | GJB2 (connexin 26) variants and nonsyndromic sensorineural hearing loss: a HuGE review. | 3.88e-06 | 2 | 69 | 2 | 12172392 | |
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 37820892 | ||
| Pubmed | Prevalence of DFNB1 mutations in Slovak patients with non-syndromic hearing loss. | 3.88e-06 | 2 | 69 | 2 | 22281373 | |
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 24774219 | ||
| Pubmed | Elimination of redundant synaptic inputs in the absence of synaptic strengthening. | 3.88e-06 | 2 | 69 | 2 | 22090494 | |
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 20381175 | ||
| Pubmed | Infant hearing loss and connexin testing in a diverse population. | 3.88e-06 | 2 | 69 | 2 | 18580690 | |
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 31200317 | ||
| Pubmed | Mechanisms of mechanotransduction and physiological roles of PIEZO channels. | 3.88e-06 | 2 | 69 | 2 | 39251883 | |
| Pubmed | Connexin channels and phospholipids: association and modulation. | 3.88e-06 | 2 | 69 | 2 | 19686581 | |
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 10805080 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 14759569 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 20563649 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 15638823 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 17695503 | ||
| Pubmed | Phenotype/genotype correlations in a DFNB1 cohort with ethnical diversity. | 3.88e-06 | 2 | 69 | 2 | 18758381 | |
| Pubmed | Performance of speech perception after cochlear implantation in DFNB1 patients. | 3.88e-06 | 2 | 69 | 2 | 19051073 | |
| Pubmed | GJB2 and GJB6 gene mutations found in Indian probands with congenital hearing impairment. | 3.88e-06 | 2 | 69 | 2 | 20086291 | |
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 37975162 | ||
| Pubmed | Non-syndromic hearing impairment in a multi-ethnic population of Northeastern Brazil. | 3.88e-06 | 2 | 69 | 2 | 23684175 | |
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 10771345 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 11668644 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 17548218 | ||
| Pubmed | Functional distinction of human EAG1 and EAG2 potassium channels. | 3.88e-06 | 2 | 69 | 2 | 11943152 | |
| Pubmed | Pediatric cholesteatoma and variants in the gene encoding connexin 26. | 3.88e-06 | 2 | 69 | 2 | 19877196 | |
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 18294049 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 19173109 | ||
| Pubmed | Transduction of Repetitive Mechanical Stimuli by Piezo1 and Piezo2 Ion Channels. | 3.88e-06 | 2 | 69 | 2 | 28636944 | |
| Pubmed | Prevalence of GJB2 mutations and the del(GJB6-D13S1830) in Argentinean non-syndromic deaf patients. | 3.88e-06 | 2 | 69 | 2 | 15964725 | |
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 19715470 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 16371502 | ||
| Pubmed | Connexins 26 and 30 are co-assembled to form gap junctions in the cochlea of mice. | 3.88e-06 | 2 | 69 | 2 | 12859965 | |
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 12865758 | ||
| Pubmed | Human cell responses to ionizing radiation are differentially affected by the expressed connexins. | 3.88e-06 | 2 | 69 | 2 | 23139176 | |
| Pubmed | Genotyping for Cx26 and Cx30 mutations in cases with congenital hearing loss. | 3.88e-06 | 2 | 69 | 2 | 18554165 | |
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 25037583 | ||
| Pubmed | Connexin gene mutations among Ugandan patients with nonsyndromic sensorineural hearing loss. | 3.88e-06 | 2 | 69 | 2 | 24706568 | |
| Pubmed | GJB2 and GJB6 mutations in 165 Danish patients showing non-syndromic hearing impairment. | 3.88e-06 | 2 | 69 | 2 | 15345117 | |
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 30324494 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 22292956 | ||
| Pubmed | Connexin 26 and 30 genes mutations in patients with chronic rhinosinusitis. | 3.88e-06 | 2 | 69 | 2 | 17989577 | |
| Pubmed | GJB2 and GJB6 screening in Tunisian patients with autosomal recessive deafness. | 3.88e-06 | 2 | 69 | 2 | 23434199 | |
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 22704424 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 19465004 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 28779115 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 15464308 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 15464305 | ||
| Pubmed | Connexin 26 and connexin 30 mutations in children with nonsyndromic hearing loss. | 3.88e-06 | 2 | 69 | 2 | 15064611 | |
| Pubmed | Analysis of the presence of the GJB6 mutations in patients heterozygous for GJB2 mutation in Brazil. | 3.88e-06 | 2 | 69 | 2 | 23553242 | |
| Pubmed | Roles of surface residues of intracellular domains of heag potassium channels. | 3.88e-06 | 2 | 69 | 2 | 19172261 | |
| Cytoband | 7p14 | 9.42e-04 | 30 | 69 | 2 | 7p14 | |
| GeneFamily | Gap junction proteins | 2.95e-05 | 22 | 50 | 3 | 314 | |
| GeneFamily | Glutamate ionotropic receptor AMPA type subunits | 4.48e-05 | 4 | 50 | 2 | 1200 | |
| GeneFamily | Glutamate ionotropic receptor NMDA type subunits | 1.56e-04 | 7 | 50 | 2 | 1201 | |
| GeneFamily | Taste 2 receptors | 1.70e-04 | 39 | 50 | 3 | 1162 | |
| GeneFamily | ATP binding cassette subfamily A | 6.68e-04 | 14 | 50 | 2 | 805 | |
| GeneFamily | Gamma-aminobutyric acid type A receptor subunits | 1.24e-03 | 19 | 50 | 2 | 563 | |
| GeneFamily | T cell receptor gamma locus at 7p14 | 1.67e-03 | 22 | 50 | 2 | 375 | |
| GeneFamily | Actins|Deafness associated genes | 3.76e-03 | 113 | 50 | 3 | 1152 | |
| GeneFamily | Potassium voltage-gated channels | 5.47e-03 | 40 | 50 | 2 | 274 | |
| GeneFamily | CD molecules|I-set domain containing|Immunoglobulin like domain containing|Interleukin receptors|TIR domain containing | 6.01e-03 | 42 | 50 | 2 | 602 | |
| CoexpressionAtlas | cerebral cortex | GABRB1 GABRB3 TMEM170B PCDHGC4 KCNH1 VSTM2L GJB6 TMCC2 NDST4 GRIA3 GRIA4 NBEA GRIK3 GRIN2A GRIN2D KCNH5 | 4.48e-06 | 1428 | 65 | 16 | cerebral cortex |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Epithelial-Bergmann_glial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.17e-07 | 184 | 69 | 6 | f6148e9591e8845cc62668e49fd52755257cdc7e | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.52e-07 | 193 | 69 | 6 | 3ed46f5a7419ec4eddbd0df0d9b5f53aa486198b | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.04e-07 | 196 | 69 | 6 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.41e-06 | 148 | 69 | 5 | d6ac5972267254651dfbe16bb4e9a62228093cc7 | |
| ToppCell | facs-Marrow-Granulocytes-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.00e-06 | 160 | 69 | 5 | bb1b966fb9e801db15e67d03e49db4609d6f935a | |
| ToppCell | facs-Marrow-Granulocytes-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.00e-06 | 160 | 69 | 5 | 56e6f4b82b5dc41c45f9d253c2db314a6f702b84 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Pecam____kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.52e-06 | 169 | 69 | 5 | 87116c33c5ca8cb1862e103e5607b1df4d264569 | |
| ToppCell | wk_08-11-Epithelial-PNS-FGFBP2+_Neural_progenitor|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 8.16e-06 | 177 | 69 | 5 | 15a5c96ea840376e54933ebe7a8334a11d9ce411 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.85e-06 | 184 | 69 | 5 | 6b0c110d8930df99043c3b99cf4d873985126960 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.85e-06 | 184 | 69 | 5 | 35928fc5f7bbf8c7b09181a2bd27e22dff42ec16 | |
| ToppCell | facs-Marrow-KLS-18m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-05 | 190 | 69 | 5 | c03c735a0ed850bf460a1847f5e2dd61753e577d | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L2-4_SST_AHR|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.18e-05 | 191 | 69 | 5 | 782bc7946417549ffd39e5b596db659436fa01ba | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.21e-05 | 192 | 69 | 5 | dc40ef2341e5d6a6d479f140e023fe1bf687928d | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.24e-05 | 193 | 69 | 5 | d1445b8bf2bab36e1a326ddb2a528151db016c7d | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.24e-05 | 193 | 69 | 5 | 2189da4b727e25e62669d7b9257f06493be21a27 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.40e-05 | 198 | 69 | 5 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.40e-05 | 198 | 69 | 5 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-FRZB|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.47e-05 | 200 | 69 | 5 | e79d93d55b25804f2608185168da472301b6ebca | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-STK32A|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.47e-05 | 200 | 69 | 5 | 8d51b4f7b7002ee51401ebe5eaca1e8f04bfadd5 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_3(PVALB-SST)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.47e-05 | 200 | 69 | 5 | 107854f4855fc99c9f7e737eb246f0d868e6c5fd | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-STK32A-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.47e-05 | 200 | 69 | 5 | 6a44439e4a7ce3627271375b04cfcfb9467218f4 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-STK32A--L4-5|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.47e-05 | 200 | 69 | 5 | cb1f4b0d66da5b0466ff17b29e7034d451d93e4f | |
| ToppCell | Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-FRZB--L2-4|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.47e-05 | 200 | 69 | 5 | 5ec469267747dce3601c1d8ad01af89fa5b29acc | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 1.47e-05 | 200 | 69 | 5 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-FRZB-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.47e-05 | 200 | 69 | 5 | 320d5a3a1e7da2fa8f1a164e29e180ec8ac9889c | |
| ToppCell | COVID-19-kidney-Mito-rich_Int|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.88e-05 | 122 | 69 | 4 | a4220adb4e6055a599bd9bbf65d460fc4e68b543 | |
| ToppCell | Thalamus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 8.23e-05 | 148 | 69 | 4 | afebb64365c94b9476494bffe7c364677f19c8cf | |
| ToppCell | Thalamus-Neuronal-Inhibitory|Thalamus / BrainAtlas - Mouse McCarroll V32 | 8.23e-05 | 148 | 69 | 4 | 5f82e5ecacfd223020b8ee975c17d68c1fe6db38 | |
| ToppCell | 367C-Myeloid-Macrophage-FABP4+_Macrophage_2|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 9.13e-05 | 152 | 69 | 4 | 7a1072315cce71eefe2d32149a107d5648999968 | |
| ToppCell | facs-Marrow-KLS-18m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-04 | 157 | 69 | 4 | 5d08ff0ba9d3df9cc30f13cab2d2b395ea6f3446 | |
| ToppCell | facs-Marrow-KLS-18m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-04 | 157 | 69 | 4 | ad9c9b7dfeee3ae46e7e593c51a0407df12195b4 | |
| ToppCell | Globus_pallidus-Neuronal-Excitatory|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.11e-04 | 160 | 69 | 4 | f843287ed57d2d5a3b3f6dfb03b6934e330e6645 | |
| ToppCell | Globus_pallidus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.14e-04 | 161 | 69 | 4 | ebcd5066e82b7760b9da6adc02d11258d1309dab | |
| ToppCell | facs-Marrow-Granulocytes-18m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.14e-04 | 161 | 69 | 4 | 60f433eab9d5531bdf6aa86b0265f20b866b904c | |
| ToppCell | droplet-Marrow-nan-18m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-04 | 162 | 69 | 4 | 08ee7ae56e4927874515c47adc86dd845bf29a26 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|kidney / Disease (COVID-19 only), tissue and cell type | 1.19e-04 | 163 | 69 | 4 | 19c28ce16a588a7f4a035c32726f6ccd67702b5b | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.19e-04 | 163 | 69 | 4 | 8e32b6431e1862572663aa6ddc4ea299c6acc8a6 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.19e-04 | 163 | 69 | 4 | bbc078761c5043af13d9a6fcf3145a3e300bae5e | |
| ToppCell | Cerebellum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.31e-04 | 167 | 69 | 4 | 9efb9511a211d0824bb97f82c1a5860c43d2138f | |
| ToppCell | Cerebellum-Neuronal-Inhibitory|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.31e-04 | 167 | 69 | 4 | 904c613aac3f9919a432b110bb1dcc832b5aec0a | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-04 | 168 | 69 | 4 | b98af4043dfa5dfa4413e482879fad88de484675 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Epithelial-hepatocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-04 | 168 | 69 | 4 | 073b53d4cee6bc8c5c6fce51cf6cd9c316478f69 | |
| ToppCell | droplet-Liver-HEPATOCYTES|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.37e-04 | 169 | 69 | 4 | f195467438c589f87224bde7da720dea072d110c | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.37e-04 | 169 | 69 | 4 | 7785cab967a33560830c394c918d6ce625103858 | |
| ToppCell | TCGA-Brain|World / Sample_Type by Project: Shred V9 | 1.40e-04 | 170 | 69 | 4 | f78e360a6a44d599ec0d207cba4704e50aa314f8 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Lymphocytic-T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.44e-04 | 171 | 69 | 4 | 246fc7edcefc47437d1df6029f295aca3b34b2b2 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Lymphocytic-Ly6g5b+_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.44e-04 | 171 | 69 | 4 | 1fb4e11f92b48dc2d6e553c22e2571bbd8c223c6 | |
| ToppCell | Bronchial_Brush-Epithelial-Ionocytes|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.50e-04 | 173 | 69 | 4 | e1de849dcd96063136bdac87e050ddbd55cabdcc | |
| ToppCell | Bronchial_Brush-Epithelial-Ionocytes|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.50e-04 | 173 | 69 | 4 | f2a8f4918c1fb68d98bc3f33cd624de0f0f11e06 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_A_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-04 | 177 | 69 | 4 | 1dc69c661e70e7e22bd9d7cf953eb638da9fd43c | |
| ToppCell | wk_15-18-Epithelial-PNS-Schwann_precursor|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.64e-04 | 177 | 69 | 4 | 5357359e6c2161a37f39a6b3b78449f5cbc327d1 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_A_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-04 | 177 | 69 | 4 | 426a9845df7fd13b02e744532c336c60bc4d4a22 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.68e-04 | 178 | 69 | 4 | 0e1bedf991189d0ef9b40dac9281bdf4739333a1 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-04 | 179 | 69 | 4 | a3922476f33d2e4137a12dbda21a1703dff79684 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature-ENCC/glia_Progenitor|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.75e-04 | 180 | 69 | 4 | c72f15763ba707189e29c85db533557f01c7fdb1 | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_SCP-neuro_SCP_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.79e-04 | 181 | 69 | 4 | fad7ba168f541ac9d04edebc206f191e48bb7e99 | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_PP_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.82e-04 | 182 | 69 | 4 | eb4be1c02b8b033d025e57b8b4cdbfaec4698054 | |
| ToppCell | PCW_05-06-Neuronal-Neuronal_SCP-neuro_proliferating_SCP2_(1)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.82e-04 | 182 | 69 | 4 | f7f9be9c7ef8da9864d6aefe20043b26e1bb8697 | |
| ToppCell | PCW_05-06-Neuronal-Neuronal_SCP|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.82e-04 | 182 | 69 | 4 | b4fc5e4f5d8440a3c9ee0a6fd0da87b43cabc8c6 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Epithelial-Bergmann_glial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.86e-04 | 183 | 69 | 4 | 99bb4ceb92f6467f2359a42ab2cff6df18825a30 | |
| ToppCell | PCW_05-06-Neuronal-Neuronal_SCP-neuro_SCP_(0)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.86e-04 | 183 | 69 | 4 | f517215ff45dec914af52dfdbc4579c19654c3aa | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Epithelial-Bergmann_glial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.86e-04 | 183 | 69 | 4 | 25c96df8ea0c7bbedbb7699ee84ad6234d19cba8 | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_SCP-neuro_proliferating_SCP2_(1)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.86e-04 | 183 | 69 | 4 | e0854864d377e158a4793088d1cb6b3dbf2c805d | |
| ToppCell | wk_08-11-Epithelial-PNS-PCP4+_neuron|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.90e-04 | 184 | 69 | 4 | eac2a9089913f33a961ba11519b53645790f2056 | |
| ToppCell | wk_08-11-Epithelial-PNS-COL20A1+_Schwann|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.94e-04 | 185 | 69 | 4 | abec2a49fe0f0fa4cba49347207a1ee317333657 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.94e-04 | 185 | 69 | 4 | bea69058afa5aa927fe15c1f8d46460562ec4dd4 | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_SCP|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.94e-04 | 185 | 69 | 4 | 56c7a0dbf141728ac76b8c90af197719942ca67c | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.94e-04 | 185 | 69 | 4 | dbbd348714cd16a4948a04648e914b1e71e2a8ef | |
| ToppCell | PCW_05-06-Neuronal-Neuronal_SCP-neuro_proliferating_SCP1_(1)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.94e-04 | 185 | 69 | 4 | a8946379fc066903fe8f4bc9cbf693b7b424a0cd | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.98e-04 | 186 | 69 | 4 | 8915436d09775f2828a7678af203b1082b36e21c | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.98e-04 | 186 | 69 | 4 | 96f6603cc75fa1ffc2a2fdb94ec0ec09498e540a | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_SCP-neuro_proliferating_SCP1_(1)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.98e-04 | 186 | 69 | 4 | 3113c85d0ac5fc46532c19b1bb71f34b985e1276 | |
| ToppCell | PCW_07-8.5-Neuronal|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.98e-04 | 186 | 69 | 4 | 7a4bb42f3f6a27b463e48eafc587d9ab3386f2fb | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.02e-04 | 187 | 69 | 4 | 85f1678338a47d91e296f0620d4887f057eb7e70 | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.02e-04 | 187 | 69 | 4 | 3699d5e71d779da922920aa3160895db187bf81b | |
| ToppCell | droplet-Fat-SCAT-30m-Epithelial|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.02e-04 | 187 | 69 | 4 | 5fada3c5a58c1890029ccbfff2608b33f8cd2df7 | |
| ToppCell | droplet-Fat-SCAT-30m-Epithelial-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.02e-04 | 187 | 69 | 4 | 766e808138fc2cd623c2e6d57fcb5c7378da0e03 | |
| ToppCell | droplet-Fat-SCAT-30m-Epithelial-epithelial_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.02e-04 | 187 | 69 | 4 | f49d06600060deeb2fc1b1da5b93496535f20104 | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.02e-04 | 187 | 69 | 4 | 033ba52c0c2f9978784947098fa697368ae44834 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_mesothelial_(19)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.02e-04 | 187 | 69 | 4 | 8e8f1f2a78ac5f13a414fd448af7d7ff1ea86f0f | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Macroglial-Schwann_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.06e-04 | 188 | 69 | 4 | 8385fd384fc55e3b17802bb6698eb93b2c16d7f2 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Hematopoietic-Red_blood_cells|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.06e-04 | 188 | 69 | 4 | f81099b5b3f1f85a28445bc663efcf73baccb2be | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Hematopoietic-Red_blood_cells-RBC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.06e-04 | 188 | 69 | 4 | 05b3ade422beeb3db73d350fe192c21bfcfef188 | |
| ToppCell | wk_08-11-Epithelial-PNS-MFNG+_DBH+_neuron|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.06e-04 | 188 | 69 | 4 | d3d7d21d4fa39ac4106a164652673de1bef8662d | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Macroglial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.06e-04 | 188 | 69 | 4 | cb9d0b48e2fd9cc576132803273b9c0382900944 | |
| ToppCell | COVID-19-Heart-CM_4|Heart / Disease (COVID-19 only), tissue and cell type | 2.15e-04 | 190 | 69 | 4 | 3729648a17093b438398b82e32bbccc3af7b8c5d | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Neuronal-neuron_precursor-Neuroblast|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.19e-04 | 191 | 69 | 4 | c7b95a5f9185d533c08754ce2e4ce91533eb612e | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-epithelial_progenitor_cell-Stem_cells|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.19e-04 | 191 | 69 | 4 | a8d77095ba20b47fc70ba04f80759fbce873253d | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Neuronal-neuron_precursor|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.24e-04 | 192 | 69 | 4 | 56f2388c9c4e19883ae5cff332c77f596ff744a8 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.28e-04 | 193 | 69 | 4 | 53bcd50892c379b2a571751f6eb1062436339fe7 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.28e-04 | 193 | 69 | 4 | c7e9e6e4bf5e07c9cbdf1aa7c8828f4b2500e3ff | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.28e-04 | 193 | 69 | 4 | 8b77625bf3c87d39767fb391d1beaca4ab02342b | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.28e-04 | 193 | 69 | 4 | 9f9eb241b0b82a6f12de6921c3acf6fed7cf65bb | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.28e-04 | 193 | 69 | 4 | 010717ca052b6c8a525a43aaeffddea0d1113e63 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.28e-04 | 193 | 69 | 4 | e74fdc8718fe0933e1f4dd3fe37e2134983b99b6 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.28e-04 | 193 | 69 | 4 | 658c2b30a4d806c5ce78ea4392fe8eb86b8d1e99 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.28e-04 | 193 | 69 | 4 | 5581a5ebcd21a2a8062ccfb917f088ec67a10a9c | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.33e-04 | 194 | 69 | 4 | 1bcb3fafd498614f7bac2b1c9b7de56e39110f65 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.33e-04 | 194 | 69 | 4 | 83863da11dfbe59b2d0a2c08db40b537c150588c | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-epithelial_progenitor_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.37e-04 | 195 | 69 | 4 | 702dc7397c4a3ee50bb97ca24b9ab0d9b07fec9b | |
| Computational | Ion channels. | 1.14e-04 | 70 | 39 | 4 | MODULE_316 | |
| Drug | felbamate | 3.37e-11 | 70 | 68 | 8 | CID000003331 | |
| Drug | AC1NUW3V | 2.55e-10 | 29 | 68 | 6 | CID005462126 | |
| Drug | cyclothiazide | 7.86e-10 | 103 | 68 | 8 | CID000002910 | |
| Drug | R,S)-AMPA | 1.03e-09 | 36 | 68 | 6 | CID000001221 | |
| Drug | CGS 19755 | 1.45e-09 | 38 | 68 | 6 | CID000068736 | |
| Drug | L-BMAA | 1.45e-09 | 38 | 68 | 6 | CID000028558 | |
| Drug | DETC-MeSO | 1.71e-09 | 39 | 68 | 6 | CID003035711 | |
| Drug | HA-966 | 1.71e-09 | 39 | 68 | 6 | CID000001232 | |
| Drug | ifenprodil | 1.76e-09 | 71 | 68 | 7 | CID000003689 | |
| Drug | 2-amino-3-phosphonopropionic acid | 2.87e-09 | 76 | 68 | 7 | CID000003857 | |
| Drug | IDRA 21 | 3.06e-09 | 20 | 68 | 5 | CID000003688 | |
| Drug | Joro spider toxin | 3.17e-09 | 43 | 68 | 6 | CID000119582 | |
| Drug | 7-chlorokynurenic acid | 4.21e-09 | 45 | 68 | 6 | CID000001884 | |
| Drug | NS 102 | 5.18e-09 | 22 | 68 | 5 | CID005282252 | |
| Drug | CX516 | 5.18e-09 | 22 | 68 | 5 | CID000148184 | |
| Drug | AC1L1B1W | 5.83e-09 | 84 | 68 | 7 | CID000001248 | |
| Drug | pentanol | 6.60e-09 | 23 | 68 | 5 | CID000006276 | |
| Drug | CGP 39653 | 8.32e-09 | 24 | 68 | 5 | CID006437837 | |
| Drug | LY354740 | 9.18e-09 | 51 | 68 | 6 | CID000114827 | |
| Drug | AC1L1EKQ | 1.04e-08 | 52 | 68 | 6 | CID000002834 | |
| Drug | GYKI 52466 | 2.03e-08 | 58 | 68 | 6 | CID000003538 | |
| Drug | pentobarbital | 2.19e-08 | 224 | 68 | 9 | CID000004737 | |
| Drug | cis-2,3-piperidine dicarboxylic acid | 2.75e-08 | 30 | 68 | 5 | CID000001226 | |
| Drug | LY293558 | 2.75e-08 | 30 | 68 | 5 | CID000127894 | |
| Drug | AC1L32TU | 2.75e-08 | 30 | 68 | 5 | CID000107831 | |
| Drug | 4-methylglutamic acid | 3.27e-08 | 31 | 68 | 5 | CID000005365 | |
| Drug | alpha-methyl-4-carboxyphenylglycine | 3.87e-08 | 32 | 68 | 5 | CID000001222 | |
| Drug | 6,7-dinitroquinoxaline | 4.55e-08 | 33 | 68 | 5 | CID002724608 | |
| Drug | riluzole | 4.95e-08 | 174 | 68 | 8 | CID000005070 | |
| Drug | D-CPPene | 5.32e-08 | 34 | 68 | 5 | CID006435801 | |
| Drug | L-Glutamic Acid | 5.36e-08 | 68 | 68 | 6 | DB00142 | |
| Drug | kainite | 6.20e-08 | 35 | 68 | 5 | CID000164810 | |
| Drug | L-quisqualic acid | 6.44e-08 | 180 | 68 | 8 | CID000001209 | |
| Drug | C6H12NO5P | 7.18e-08 | 36 | 68 | 5 | CID000104962 | |
| Drug | gamma-Glu-Gly | 8.28e-08 | 37 | 68 | 5 | CID000100099 | |
| Drug | ketamine | 8.41e-08 | 262 | 68 | 9 | CID000003821 | |
| Drug | GAMs | 9.51e-08 | 38 | 68 | 5 | CID000002935 | |
| Drug | thiokynurenic acid | 9.69e-08 | 15 | 68 | 4 | CID003035667 | |
| Drug | AC1L1DME | 9.70e-08 | 75 | 68 | 6 | CID000002414 | |
| Drug | Kainic Acid | 1.15e-07 | 194 | 68 | 8 | ctd:D007608 | |
| Drug | LY233536 | 1.29e-07 | 16 | 68 | 4 | CID000126239 | |
| Drug | QX-314 | 1.66e-07 | 82 | 68 | 6 | CID000003925 | |
| Drug | 7-Cl-Thio-Kyna | 1.68e-07 | 17 | 68 | 4 | CID003035668 | |
| Drug | LY341495 | 1.80e-07 | 43 | 68 | 5 | CID006324636 | |
| Drug | MNQX | 2.16e-07 | 18 | 68 | 4 | CID000130818 | |
| Drug | philanthotoxin | 2.28e-07 | 45 | 68 | 5 | CID000115201 | |
| Drug | hexachlorophene | 2.90e-07 | 90 | 68 | 6 | CID000003598 | |
| Drug | aurintricarboxylic acid | 3.09e-07 | 91 | 68 | 6 | CID000002259 | |
| Drug | 2-amino-4-phosphonobutyric acid | 3.09e-07 | 91 | 68 | 6 | CID000002207 | |
| Drug | avermectin | 3.17e-07 | 48 | 68 | 5 | CID006450460 | |
| Drug | methylenecyclopropylglycine | 3.52e-07 | 49 | 68 | 5 | CID000441452 | |
| Drug | 5,7-dichlorokynurenic acid | 3.52e-07 | 49 | 68 | 5 | CID000001779 | |
| Drug | AC1L1FA8 | 3.91e-07 | 50 | 68 | 5 | CID000003150 | |
| Drug | Cascade Blue | 4.19e-07 | 21 | 68 | 4 | CID000014886 | |
| Drug | Quinoxaline | 4.77e-07 | 52 | 68 | 5 | CID000007045 | |
| Drug | YM90K | 6.17e-07 | 23 | 68 | 4 | CID005486547 | |
| Drug | gavestinel | 8.78e-07 | 25 | 68 | 4 | CID006450546 | |
| Drug | MPEP | 9.04e-07 | 59 | 68 | 5 | CID003025961 | |
| Drug | 3,5-dihydroxyphenylglycine | 9.84e-07 | 60 | 68 | 5 | CID000108001 | |
| Drug | AC1Q3ZOL | 1.00e-06 | 258 | 68 | 8 | CID000002376 | |
| Drug | propionate | 1.13e-06 | 262 | 68 | 8 | CID000001032 | |
| Drug | picrotoxin | 1.15e-06 | 181 | 68 | 7 | CID000031304 | |
| Drug | L-689,560 | 1.21e-06 | 27 | 68 | 4 | CID000121918 | |
| Drug | aptiganel | 1.41e-06 | 28 | 68 | 4 | CID000060839 | |
| Drug | C-PP | 1.41e-06 | 28 | 68 | 4 | CID000001228 | |
| Drug | oleylamide | 1.41e-06 | 8 | 68 | 3 | ctd:C029407 | |
| Drug | 17-isoprogesterone | GABRB1 GABRB3 GJB1 GJB2 WWOX PCDHGC4 ABCA5 GJB6 GRIA3 GRIA4 GRID2 GRIK3 GRIN2A GRIN2D G6PC2 | 1.43e-06 | 1170 | 68 | 15 | CID000004920 |
| Drug | ketobemidone | 1.63e-06 | 29 | 68 | 4 | CID000010101 | |
| Drug | ibotenic acid | 1.75e-06 | 122 | 68 | 6 | CID000001233 | |
| Drug | kynurenic acid | 1.75e-06 | 122 | 68 | 6 | CID000003845 | |
| Drug | isoflurane | 1.80e-06 | 279 | 68 | 8 | CID000003763 | |
| Drug | enflurane | 1.84e-06 | 68 | 68 | 5 | CID000003226 | |
| Drug | GYKI 53655 | 1.88e-06 | 30 | 68 | 4 | CID000126757 | |
| Drug | Ly294486 | 2.11e-06 | 9 | 68 | 3 | CID005311255 | |
| Drug | LY235959 | 2.15e-06 | 31 | 68 | 4 | CID000131938 | |
| Drug | NPC 12626 | 2.15e-06 | 31 | 68 | 4 | CID000108099 | |
| Drug | eliprodil | 2.15e-06 | 31 | 68 | 4 | CID000060703 | |
| Drug | T2755 | 2.29e-06 | 71 | 68 | 5 | CID000005514 | |
| Drug | AP-5 | 2.31e-06 | 128 | 68 | 6 | CID000001216 | |
| Drug | aniracetam | 2.53e-06 | 130 | 68 | 6 | CID000002196 | |
| Drug | pentylenetetrazol | 2.53e-06 | 130 | 68 | 6 | CID000005917 | |
| Drug | haloperidol | 2.54e-06 | 394 | 68 | 9 | CID000003559 | |
| Drug | AC1L9FMM | 2.63e-06 | 73 | 68 | 5 | CID000444055 | |
| Drug | 1-aminoindan-1,5-dicarboxylic acid | 2.79e-06 | 33 | 68 | 4 | CID000002071 | |
| Drug | MK-801 | 2.79e-06 | 296 | 68 | 8 | CID000001207 | |
| Drug | PhTX-343 | 3.99e-06 | 36 | 68 | 4 | CID000159548 | |
| Drug | gacyclidine | 3.99e-06 | 36 | 68 | 4 | CID000176265 | |
| Drug | glutamic acid diethyl ester | 3.99e-06 | 36 | 68 | 4 | CID000073960 | |
| Drug | sym 2206 | 4.13e-06 | 11 | 68 | 3 | CID005039877 | |
| Drug | DE gel | 4.39e-06 | 143 | 68 | 6 | CID000008146 | |
| Drug | 4CPG | 4.97e-06 | 38 | 68 | 4 | CID000005115 | |
| Drug | tetradotoxin | GABRB1 GABRB3 KIDINS220 GRIA3 GRIA4 GRID2 GRIK3 GRIN2A GRIN2D | 4.98e-06 | 428 | 68 | 9 | CID000020382 |
| Drug | D-N-Q | 5.26e-06 | 84 | 68 | 5 | CID000003140 | |
| Drug | Atpa | 5.50e-06 | 12 | 68 | 3 | CID000002252 | |
| Drug | memantine | 5.91e-06 | 86 | 68 | 5 | CID000004054 | |
| Drug | NSC759587 | 6.69e-06 | 444 | 68 | 9 | CID000003816 | |
| Drug | L000369 | 6.78e-06 | 41 | 68 | 4 | CID003931705 | |
| Drug | AC1NNRU4 | 6.78e-06 | 41 | 68 | 4 | CID005126051 | |
| Drug | adamantane | 6.78e-06 | 41 | 68 | 4 | CID000009238 | |
| Drug | pregnanolone | 7.39e-06 | 90 | 68 | 5 | CID000031402 | |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 3.96e-06 | 49 | 64 | 4 | DOID:0060037 (implicated_via_orthology) | |
| Disease | autosomal recessive nonsyndromic deafness 1A (implicated_via_orthology) | 4.63e-06 | 2 | 64 | 2 | DOID:0110475 (implicated_via_orthology) | |
| Disease | Keratitis-Ichthyosis-Deafness Syndrome | 4.63e-06 | 2 | 64 | 2 | C3665333 | |
| Disease | DFNA 3 Nonsyndromic Hearing Loss and Deafness | 4.63e-06 | 2 | 64 | 2 | cv:CN043589 | |
| Disease | Senter syndrome | 4.63e-06 | 2 | 64 | 2 | C0265336 | |
| Disease | autosomal recessive nonsyndromic deafness 1A (is_implicated_in) | 4.63e-06 | 2 | 64 | 2 | DOID:0110475 (is_implicated_in) | |
| Disease | Deafness, autosomal dominant nonsyndromic sensorineural 3 | 1.39e-05 | 3 | 64 | 2 | cv: | |
| Disease | Progressive hearing loss stapes fixation | 1.39e-05 | 3 | 64 | 2 | C1844678 | |
| Disease | DEAFNESS, AUTOSOMAL RECESSIVE 1A | 1.39e-05 | 3 | 64 | 2 | 220290 | |
| Disease | DEAFNESS, DIGENIC, GJB2/GJB6 (disorder) | 1.39e-05 | 3 | 64 | 2 | C2673760 | |
| Disease | DEAFNESS, DIGENIC, GJB2/GJB3 (disorder) | 1.39e-05 | 3 | 64 | 2 | C2673761 | |
| Disease | DEAFNESS, AUTOSOMAL RECESSIVE 1A (disorder) | 1.39e-05 | 3 | 64 | 2 | C2673759 | |
| Disease | X-linked mixed hearing loss with perilymphatic gusher | 1.39e-05 | 3 | 64 | 2 | cv:C1844678 | |
| Disease | DEAFNESS, X-LINKED 2 | 1.39e-05 | 3 | 64 | 2 | 304400 | |
| Disease | Autosomal recessive nonsyndromic hearing loss 1A | 1.39e-05 | 3 | 64 | 2 | cv:C2673759 | |
| Disease | autoimmune thyroiditis (biomarker_via_orthology) | 2.77e-05 | 4 | 64 | 2 | DOID:7188 (biomarker_via_orthology) | |
| Disease | epilepsy (implicated_via_orthology) | 2.83e-05 | 163 | 64 | 5 | DOID:1826 (implicated_via_orthology) | |
| Disease | Hidrotic Ectodermal Dysplasia | 4.61e-05 | 5 | 64 | 2 | C0162361 | |
| Disease | Epilepsy | 9.44e-05 | 109 | 64 | 4 | C0014544 | |
| Disease | Distal arthrogryposis | 1.65e-04 | 9 | 64 | 2 | cv:C0265213 | |
| Disease | Nonsyndromic Hearing Loss and Deafness, Autosomal Recessive | 1.88e-04 | 51 | 64 | 3 | cv:CN043650 | |
| Disease | fish oil supplement exposure measurement, triglyceride measurement | 2.06e-04 | 10 | 64 | 2 | EFO_0004530, EFO_0600007 | |
| Disease | cognitive function measurement | GABRB1 TMEM170B WWOX SZT2 PIEZO1 ABCC5 GRIA4 GRID2 NBEA GRIN2A ARMH3 | 2.38e-04 | 1434 | 64 | 11 | EFO_0008354 |
| Disease | quality of life during menstruation measurement, dysmenorrheic pain measurement | 2.52e-04 | 11 | 64 | 2 | EFO_0007889, EFO_0009366 | |
| Disease | HETE measurement | 3.36e-04 | 62 | 64 | 3 | EFO_0801166 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 3.38e-04 | 152 | 64 | 4 | DOID:0060041 (implicated_via_orthology) | |
| Disease | central nervous system disease (implicated_via_orthology) | 5.45e-04 | 16 | 64 | 2 | DOID:331 (implicated_via_orthology) | |
| Disease | Nonsyndromic genetic hearing loss | 6.11e-04 | 76 | 64 | 3 | cv:C5680182 | |
| Disease | extrahepatic cholestasis (biomarker_via_orthology) | 6.17e-04 | 17 | 64 | 2 | DOID:13619 (biomarker_via_orthology) | |
| Disease | Epilepsy, Cryptogenic | 7.63e-04 | 82 | 64 | 3 | C0086237 | |
| Disease | Awakening Epilepsy | 7.63e-04 | 82 | 64 | 3 | C0751111 | |
| Disease | Aura | 7.63e-04 | 82 | 64 | 3 | C0236018 | |
| Disease | Deaf Mutism | 8.58e-04 | 20 | 64 | 2 | C4082305 | |
| Disease | Deafness, Acquired | 8.58e-04 | 20 | 64 | 2 | C0751068 | |
| Disease | Hearing Loss, Extreme | 8.58e-04 | 20 | 64 | 2 | C0086395 | |
| Disease | Complete Hearing Loss | 8.58e-04 | 20 | 64 | 2 | C0581883 | |
| Disease | Prelingual Deafness | 8.58e-04 | 20 | 64 | 2 | C0011052 | |
| Disease | Bilateral Deafness | 8.58e-04 | 20 | 64 | 2 | C3665473 | |
| Disease | hearing impairment | 1.28e-03 | 98 | 64 | 3 | C1384666 | |
| Disease | Deafness | 1.35e-03 | 25 | 64 | 2 | C0011053 | |
| Disease | revision of total knee arthroplasty | 1.46e-03 | 26 | 64 | 2 | EFO_0020972 | |
| Disease | Autosomal dominant nonsyndromic hearing loss | 1.81e-03 | 29 | 64 | 2 | cv:C5779548 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GLHDTAFWLSWVLLY | 256 | Q8WWZ7 | |
| LRESAFWLSWGLTYI | 171 | Q8WWZ4 | |
| RHFVSWLWYEREVTL | 96 | Q6P575 | |
| TWPTRLHRLTAYSWD | 211 | Q5T5M9 | |
| RVRLHYTWRELWSAL | 486 | Q5T2E6 | |
| SLWWTYTSSIFFRVI | 131 | P29033 | |
| EVFYWTHLSYLLVWL | 396 | Q96PH1 | |
| DYRLSWHLWEVLRAL | 1521 | P52948 | |
| WHLWEVLRALNYTHL | 1526 | P52948 | |
| WAWVLSTRLARHIGY | 556 | Q9ULH0 | |
| AHSAGLTLIWYWTRQ | 61 | Q9NPH3 | |
| FHWRRSYAVHITSFW | 486 | P22083 | |
| VLYWRTTAFSVWTKV | 241 | Q6UXG2 | |
| TWDWVILILTFYTAI | 216 | Q8NCM2 | |
| VWWFFTLIIISSYTA | 636 | P42263 | |
| VWWFFTLIIISSYTA | 626 | P48058 | |
| AWWLFALIVISSYTA | 636 | O43424 | |
| YLLNLFRLWWHYGIS | 126 | Q8NBM8 | |
| LHYCVFKTTWDWIIL | 211 | O95259 | |
| YWFFWSIFILSLARI | 26 | Q6W3E5 | |
| LITILSWVSFWINYD | 256 | P18505 | |
| LITILSWVSFWINYD | 256 | P28472 | |
| WYAVHIERWLTYFAT | 746 | Q9H3R1 | |
| IWRWATLLFLFYHLG | 11 | Q9Y5F7 | |
| LLHWWTEASYSRFLR | 631 | O95672 | |
| WVLAWYRARRAVTLH | 61 | Q13724 | |
| IRTLNAYDHRWLWYV | 286 | O00254 | |
| VRSWSLALTWALNYR | 231 | O15440 | |
| LWDSRLFAYSSWEIL | 321 | Q04446 | |
| YYNSWALILHATALW | 1491 | Q86XA9 | |
| WLEVHYWTSRFLIIN | 351 | Q9NZS9 | |
| SLWWTYTSSIFFRII | 131 | O95452 | |
| HRLTWSFLWSVFWLI | 146 | Q9NQR9 | |
| HISGTLWWTYVISVV | 126 | P08034 | |
| LWWTYVISVVFRLLF | 131 | P08034 | |
| SVLYTVTLWVESWAR | 106 | P42701 | |
| IWWFFTLIIISSYTA | 641 | Q13003 | |
| WEHFQSLLWTYSRLR | 146 | Q92902 | |
| LKSARYFLWHTYRWL | 1951 | Q9HC10 | |
| EAFWWRASRLYTLVL | 196 | P48145 | |
| ISRLRHYLLSQGWWD | 361 | P12694 | |
| WVSYQLLDVRAWSSL | 96 | Q14773 | |
| VGLLWVILLHWYSTV | 56 | P59543 | |
| LKQTFLSVLWHVRYW | 286 | P59540 | |
| LASLSRYLYHQRWLW | 786 | Q5T011 | |
| LVLFLLWKHWDSLTY | 686 | O75069 | |
| LWKHWDSLTYLLEHV | 691 | O75069 | |
| SRIEWVWLHWSEYLL | 106 | Q6ZMZ3 | |
| YWIFLWALFSSLFVH | 36 | Q5T4T1 | |
| ATLLLWYWSGRHHII | 2746 | Q8NFP9 | |
| WSSRALLYLTLWFFF | 71 | P0CK97 | |
| YYTHTPRRWSWILRL | 86 | P03979 | |
| YYTHTPRRWSWILIL | 86 | A0A0B4J1U4 | |
| FIRILQLVWHTTVWY | 261 | Q15399 | |
| VTLKLALDTHYWTWI | 1016 | P98196 | |
| TSWHLAYLITWTTCL | 196 | Q6UE05 | |
| YLTARHDWLNIILWI | 886 | Q96JI7 | |
| LFQSSRWLRYLSIFW | 71 | Q9NYW4 | |
| RWLRYLSIFWVLVSQ | 76 | Q9NYW4 | |
| WLLSHYAWRGSLLLV | 161 | Q7RTY0 | |
| ITGRHWLAREYVWFL | 66 | Q8TBR7 | |
| VRSIACWTLSRYAHW | 451 | O14787 | |
| HISWSYVWRTYHLTS | 86 | Q9BV90 | |
| WSITYHSWLTFVLLI | 511 | Q9H5I5 | |
| HSWLTFVLLIWSCTL | 516 | Q9H5I5 | |
| IHRSWWVYTLLFTLA | 331 | Q9NZC7 | |
| WSSRALLYLTLWFFF | 71 | P0CK96 | |
| TEIWFLDRALYWHFL | 171 | Q68CL5 | |
| WLTVTSALTYHLWRD | 141 | Q5TGU0 | |
| ITYHSWLTFVLLLWA | 436 | Q92508 | |
| SYSLEIQWWYVRSHR | 71 | Q96N03 | |
| TWHSLRALVYRVWSL | 111 | Q6AWC8 | |
| WLWHSIVIRMYLSLI | 676 | Q99959 | |
| SLITFIWEHLFYWKL | 831 | Q12879 | |
| LVFAWEHLVYWRLRH | 861 | O15399 |